Results
Our company has validated results to be the leader in development of the next generation of novel cancer immunotherapies with our global team of scientific and commercial immunotherapy, immunonology, and oncology experts
Taking Immunotherapy to the Next Level
Discovery
ImmunOs Therapeutics AG is a biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in innate immunity
ImmunOs Therapeutics AG is leading the next generation of immunotherapies by fast-tracking new discoveries of novel human immunomodulatory proteins that have a role in the innate immune system for cancer treatment
Pipeline
A growing pipeline of novel drug candidates to antagonize multiple types of cancer tumors using the innate immune system
People
Our mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease